Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Incyte (INCY) has a market cap of $14.05 billion USD. According to our data, Incyte is ranked No.1262 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $14.05 B |
5.60%
|
| Dec 31, 2024 | $13.31 B |
10.00%
|
| Dec 29, 2023 | $12.10 B |
-21.83%
|
| Dec 30, 2022 | $15.47 B |
9.43%
|
| Dec 31, 2021 | $14.14 B |
-15.61%
|
| Dec 31, 2020 | $16.76 B |
-0.39%
|
| Dec 31, 2019 | $16.82 B |
37.32%
|
| Dec 31, 2018 | $12.25 B |
-32.86%
|
| Dec 29, 2017 | $18.25 B |
-5.55%
|
| Dec 30, 2016 | $19.32 B |
-7.54%
|
| Dec 31, 2015 | $20.89 B |
48.34%
|
| Dec 31, 2014 | $14.08 B |
44.40%
|
| Dec 31, 2013 | $9.75 B |
204.82%
|
| Dec 31, 2012 | $3.20 B |
10.66%
|
| Dec 30, 2011 | $2.89 B |
-9.36%
|
| Dec 31, 2010 | $3.19 B |
81.78%
|
| Dec 31, 2009 | $1.76 B |
140.37%
|
| Dec 31, 2008 | $0.73 B |
-62.29%
|
| Dec 31, 2007 | $1.94 B |
72.09%
|
| Dec 29, 2006 | $1.13 B |
9.36%
|
| Dec 30, 2005 | $1.03 B |
-46.55%
|
| Dec 31, 2004 | $1.92 B |
46.05%
|
| Dec 31, 2003 | $1.32 B |
50.00%
|
| Dec 31, 2002 | $0.88 B |
-76.54%
|
| Dec 31, 2001 | $3.75 B |
-21.85%
|
| Dec 29, 2000 | $4.79 B |
-17.08%
|
| Dec 31, 1999 | $5.78 B |
60.54%
|
| Dec 31, 1998 | $3.60 B |
-16.94%
|
| Dec 31, 1997 | $4.33 B |
74.76%
|
| Dec 31, 1996 | $2.48 B |
106.00%
|
| Dec 29, 1995 | $1.20 B |
80.18%
|
| Dec 30, 1994 | $0.67 B |
54.17%
|
| Dec 31, 1993 | $0.43 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
 Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
 Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
 Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
 AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
 Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
 Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
 Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
 AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
| Market Cap | = | INCY Stock Price | * | INCY Shares Outstanding |
| = | $72.94 | * | 0.19 B | |
| = | $14.05 B |